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To the Editor:
Among live-births generally more males are born
than females. In Switzerland sex ratio of healthy
newbornswas 1.04 (male to female: 37,340 to 35,742)
in 2004 [Bundesamt fu¨r Statistik, 2005]. Considering
the higher prenatal loss rate of males, Huether [1990]
extrapolated a sex ratio at conception for whites of
approximately 1.15.
Trisomy 18 is a multiple malformation syndrome;
many of the live-born children die during the first
days of life. For fetuses with trisomy 18 diagnosed at
amniocentesis (usually at about 16–20 gestational
weeks), Hook et al. [1983] calculated a fetal survival
coefficient of 0.32. Hook et al. [1989] further
observed spontaneous fetal death in 81.8% (9 of
11) of males and 58.3% (7 of 12) of females. Distinctly
more females than males are born alive [Ferguson-
Smith, 1962; Weber, 1967; Taylor, 1968; Goldstein
and Nielson, 1988; Root and Carey, 1994]. Huether
et al. [1996] reported a substantial loss of males with
trisomy 18 during the second half of fetal develop-
ment. They reported a prenatal sex ratio of 0.9 for
trisomy 18 before and after 16 weeks of gestation and
of 0.69 at birth. Not only are more males lost during
pregnancy, but also the survival after birth for males
seems to be significantly shorter than that of females
[Weber, 1967; Van Dyke and Allen, 1990; Root and
Carey, 1994; Rasmussen et al., 2003; Niedrist et al.,
2006]. Since most of the first trimester pregnancies
with trisomy 18 are terminated after prenatal
diagnosis, we know little about what would have
been the spontaneous outcome for the different
sexes. In order to get all available information about
the change of the sex ratio in pregnancies with
trisomy 18, we collected data about the sex distribu-
tion at the timeof cytogenetic diagnosis. In this study,
we included not only the prenatally examined cases
but also the postnatally detected cases (spontaneous
abortions, stillborns, and live-borns) in whom the
gestational age at birth was known in order not to
miss sex differences in the third trimester of
pregnancy.
We collected data on 352 cases with trisomy 18
from two cytogenetic laboratories in Zurich between
January 1964 and May 2003. Part of this study has
already been published elsewhere [Niedrist et al.,
2006]. For the present study the information about
the time of gestation is based on the data given by the
referring doctors on the application form and the
information about the karyotype on the cytogenetic
laboratory results. The time of the chorionic villus
sampling or amniocentesis in our study was decided
by the referring doctors and we collected the data
retrospectively. Cases of mosaic trisomy 18 were
excluded. In prenatal cases we registered the
gestational age at the time of the first cytogenetic
examination. If there has been no prenatal interven-
tion, we used, in live- or stillborn children, the
gestational age at delivery. For statistical analysis we
used SPSS version 13 [2000–2006]. Approval by an
ethics committee or Institutional Review Board was
not required by the authors’ institution for the
present study.
In 320 cases of trisomy 18 the week of gestation
at the time of cytogenetic intervention and the
sex were known (Fig. 1). In 194 cases the cytogene-
tic diagnosis was obtained prenatally (94 males,
100 females) and in 126 cases (41 males, 85 females)
the diagnosis was performed postnatally. In 32 cases
either the week of gestation at diagnosis/birth or the
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sex was not known: 14 males, 15 females, 3 cases of
unknown sex, 6 prenatal diagnoses, 26 postnatal
diagnoses.
In the present study population 103 females and 58
males with trisomy 18 were born alive (sex ratio 0.56)
[published data in Niedrist et al., 2006]. This sex ratio
of just 36% males (95% CI: 28.6–43.4% males) is
significantly different from the sex ratio of 1.04 of
healthy newborns in Switzerland 2004 (binomial test,
P< 0.05).
For cases with trisomy 18 diagnosed between 10
and 160/7 weeks of gestation, the sex ratio was 1.02
(60 males/59 females), between 161/7 and 28
0/7
weeks it was 0.82 (27/33), and between 281/7 and
43 weeks it was 0.52 (48/93). The sex ratios in the
different time periods are significantly different
(Pearson chi-square P< 0.05).
The sex ratios before (66 males, 68 females) and
after (69 males, 117 females) 18 weeks of gestation
are significantly different as well (Pearson chi-square
P< 0.05). The sex ratio in our study before 18 weeks
of gestation is not significantly different from the sex
ratio at conception for whites of approximately 1.15
or the sex ratio for healthy newborns in Switzerland
2004 of 1.04 (binomial test, P> 0.05). On the basis of
the fetal death rate for trisomy 18 after amniocentesis
of about 68% [Hook et al., 1983] and the live-born sex
ratio in our study group of 0.56, we calculated a risk
of about 60% of fetal demise for female fetuses after
18 weeks of gestation till live-birth, while for male
fetuses, this rate would be about 77% (Table I). The
odds ratio is 2.2.
When calculating the risk for fetal demise between
18 weeks of gestation and live-birth, we used the
referral data of Hook et al. [1983]. They collected data
from cytogenetically confirmed trisomy 18 pregnan-
cies, as we did in our study. They based their figures
on pregnancies where onset of the observation
FIG. 1. Diagrammatic representation of males versus females at different stages of pregnancy. Data from 320 cases with trisomy 18 from Niedrist et al. [2006].
TABLE I. Comparison Between Sex Ratios and Numbers of Males and Females With trisomy 18
Diagnosed Before and After 18 Weeks of Gestation and at Delivery of Live-Born
Weeks of gestation at the time of cytogenetic
diagnosis
Live-born
children10–176/7 weeks 18
0/7–43 weeks
Number of males with trisomy 18 66 69 58
% aliveb 49% 11.5%
Number of females with trisomy 18 68 117 103
% aliveb 51% 20.5%
Sex ratio 0.97* 0.59* 0.56a
% aliveb 100% 32%
*Significantly different, Pearson chi-square P< 0.05.
aSignificantly different to the live-born sex ratio in Switzerland 2004, binomial test P< 0.05.
bPercent alive figures were calculated assuming a fetal survival coefficient of 0.32 [Hook et al., 1983].
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was defined as usually 16–20 gestational weeks.
These results were similar to Hook [1978]; Hook et al.
[1989]; and Embleton et al. [1996]. In the literature,
there are studies with a lower risk for fetal demise in
trisomy 18 [Won et al., 2005], but these studies were
either not based on cytogenetic laboratory reporting,
or the median onset of observation is later in
pregnancy.
The present study confirms the observation by
Hook et al. [1989] and the results from Huether et al.
[1996] andpresentsmoredetails in risk calculation for
the different sexes in prenatal diagnosis of trisomy
18. We conclude on the basis of this study that in
trisomy 18 after 18 weeks of gestation, the risk for
intrauterine demise in males is twice as high as the
risk for intrauterine demise in females. In postnatal
survival studies there has already been shown a
twofold risk for death in males compared with
females [Niedrist et al., 2006]. Our results now show
that this risk already exists prenatally after 18 weeks
of gestation and that there is a continuous twofold
higher prenatal and postnatal loss of male versus
female probands with trisomy 18. No specific pattern
for timing of loss in trisomy 18 fetuses after diagnostic
amniocentesis was shown by Won et al. [2005].
We further conclude that the probability of
intrauterine death for fetuses diagnosed with trisomy
18 during the first and early second trimester of
pregnancy must be provided differently for female
versus male fetuses. This statistic must be considered
at genetic counseling when prenatal diagnosis
discloses fetal trisomy 18.
There are no reports in the literature about
differences in the number of male and female cases
with trisomy 18 at conception. We assume that the
time of cytogenetic examination in a pregnancy with
fetal trisomy 18 is independent from the sex of the
fetus. To the best of our knowledge, there is no hint
in the literature for differences in the incidence and
severity of malformations between males and
females with trisomy 18, which secondary to fetal
ultrasonographic anomalies, would cause earlier or
more frequent diagnosis in male as compared to
female fetuses. The time of gestation in our study is
based on the data obtained from the referring
gynecologists and the determination of the sex on
the karyotype; for both, we assume a high accuracy.
In just 32 cases either the week of gestation at
diagnosis/birth or the sex was not known. We
assume these cases would have had no or only small
influence on the results of the present study.
Up to now the reasons for the excessive loss of
males before and after birth are not known. Further
studies on this issue are necessary.
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